Complications (%) in patients randomized to busulfan (Bu) or TBI regarding alopecia, long-term immunosuppression (IS) with CsA and/or steroids (>5 years), chronic GVHD (cGVHD), cataract, obstructive bronchiolitis (OB), liver VOD, and hemorrhagic cystitis.